Treatment Patterns and Outcomes of Targeted Therapy and Immunotherapy Among BRAF-Positive Melanoma Patients Treated in the Adjuvant Setting and Among BRAF-Positive Metastatic Melanoma Patients With Low Tumor Burden
N/A
This was an observational study utilizing electronic health record (EHR)-de...
A Study of Cobimetinib Administered as Single Agent and in Combination With Venetoclax, With or Without Atezolizumab, in Participants With Relapsed and Refractory Multiple Myeloma
PHASE1
This open-label, randomized, multicenter, triple-arm Phase Ib/II study is d...
Status
Completed
Location
Fakultni nemocnice Brno; Interni hematologicka a onkologicka klinika
TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage Cancer
PHASE2
The purpose of the study is to learn from the real world practice of prescr...
Status
Recruiting
Location
University of Alabama at Birmingham Comprehensive Cancer Center